HK1016180A1 - Process for the preparation of anti-malarial drugs - Google Patents

Process for the preparation of anti-malarial drugs

Info

Publication number
HK1016180A1
HK1016180A1 HK99101378A HK99101378A HK1016180A1 HK 1016180 A1 HK1016180 A1 HK 1016180A1 HK 99101378 A HK99101378 A HK 99101378A HK 99101378 A HK99101378 A HK 99101378A HK 1016180 A1 HK1016180 A1 HK 1016180A1
Authority
HK
Hong Kong
Prior art keywords
preparation
malarial drugs
malarial
drugs
Prior art date
Application number
HK99101378A
Other languages
English (en)
Inventor
Cletus Onwuzurike Ugwuegbulam
James Edward Foy
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of HK1016180A1 publication Critical patent/HK1016180A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK99101378A 1995-10-13 1999-04-07 Process for the preparation of anti-malarial drugs HK1016180A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9521004.3A GB9521004D0 (en) 1995-10-13 1995-10-13 Process
PCT/EP1996/004433 WO1997013753A1 (en) 1995-10-13 1996-10-11 Process for the preparation of anti-malarial drugs

Publications (1)

Publication Number Publication Date
HK1016180A1 true HK1016180A1 (en) 1999-10-29

Family

ID=10782264

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101378A HK1016180A1 (en) 1995-10-13 1999-04-07 Process for the preparation of anti-malarial drugs

Country Status (28)

Country Link
US (1) US6479660B1 (xx)
EP (1) EP0871616B1 (xx)
JP (1) JP4083803B2 (xx)
KR (1) KR100453256B1 (xx)
CN (1) CN1147475C (xx)
AR (1) AR004015A1 (xx)
AT (1) ATE214372T1 (xx)
AU (1) AU709333B2 (xx)
BR (1) BR9611010A (xx)
CA (1) CA2231633C (xx)
CZ (1) CZ290380B6 (xx)
DE (1) DE69619863T2 (xx)
DK (1) DK0871616T3 (xx)
ES (1) ES2170874T3 (xx)
GB (1) GB9521004D0 (xx)
HK (1) HK1016180A1 (xx)
HU (1) HUP9900739A3 (xx)
IL (1) IL124060A (xx)
NO (1) NO313285B1 (xx)
NZ (1) NZ320209A (xx)
PL (1) PL186055B1 (xx)
PT (1) PT871616E (xx)
SA (1) SA97170574B1 (xx)
SI (1) SI0871616T1 (xx)
TR (1) TR199800637T2 (xx)
TW (1) TW450950B (xx)
WO (1) WO1997013753A1 (xx)
ZA (1) ZA968550B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08276712A (ja) * 1995-04-05 1996-10-22 Masao Tsuji チュ−ブレススパイクタイヤ
GB0210150D0 (en) * 2002-05-03 2002-06-12 Smithkline Beecham Plc Process
WO2007032016A1 (en) * 2005-09-12 2007-03-22 Council Of Scientific And Industrial Research An antimalarial baylis-hillman adducts and a process for the preparation thereof
WO2007127930A2 (en) * 2006-04-28 2007-11-08 Kansas State University Research Foundation Compounds affecting gap junction activity
GB0620005D0 (en) 2006-10-10 2006-11-22 Glaxo Group Ltd Compounds
US20090076072A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched tafenoquine
ES2453206B1 (es) 2013-09-25 2015-01-12 Thyssenkrupp Elevator Innovation Center, S.A. Sistema de tracción para un sistema de transporte
CN113248431A (zh) * 2021-05-21 2021-08-13 重庆医药高等专科学校 一种磷酸伯氨喹的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US4617394A (en) 1985-10-15 1986-10-14 The United States Of America As Represented By The Secretary Of The Army 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines

Also Published As

Publication number Publication date
NZ320209A (en) 1999-08-30
KR100453256B1 (ko) 2004-12-17
NO313285B1 (no) 2002-09-09
ES2170874T3 (es) 2002-08-16
HUP9900739A2 (hu) 1999-09-28
AU709333B2 (en) 1999-08-26
SA97170574B1 (ar) 2006-09-25
ATE214372T1 (de) 2002-03-15
US6479660B1 (en) 2002-11-12
DE69619863T2 (de) 2002-11-21
EP0871616A1 (en) 1998-10-21
BR9611010A (pt) 1999-07-13
IL124060A (en) 2003-07-31
AR004015A1 (es) 1998-09-30
JPH11513399A (ja) 1999-11-16
PL186055B1 (pl) 2003-09-30
PT871616E (pt) 2002-07-31
TW450950B (en) 2001-08-21
NO981537L (no) 1998-04-03
JP4083803B2 (ja) 2008-04-30
AU7291096A (en) 1997-04-30
CZ110398A3 (cs) 1998-09-16
CN1199395A (zh) 1998-11-18
ZA968550B (en) 1998-04-14
CZ290380B6 (cs) 2002-07-17
WO1997013753A1 (en) 1997-04-17
EP0871616B1 (en) 2002-03-13
PL326194A1 (en) 1998-08-31
CA2231633A1 (en) 1997-04-17
DK0871616T3 (da) 2002-07-01
TR199800637T2 (xx) 1998-07-21
GB9521004D0 (en) 1995-12-13
HUP9900739A3 (en) 1999-11-29
SI0871616T1 (en) 2002-12-31
KR19990064210A (ko) 1999-07-26
DE69619863D1 (de) 2002-04-18
CA2231633C (en) 2006-10-03
CN1147475C (zh) 2004-04-28
NO981537D0 (no) 1998-04-03

Similar Documents

Publication Publication Date Title
IL117188A0 (en) Process for the preparation of thietanones
SG55239A1 (en) Process for the preparation of dihaloazpyrimidines
IL124768A0 (en) Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents
SI0877738T1 (en) Process for the preparation of phenylimidazolidine derivatives
HK1016180A1 (en) Process for the preparation of anti-malarial drugs
HUP9903481A3 (en) Process for the preparation of 1-aryl-1-cyanocyclobutane derivatives
ZA962538B (en) Process for the preparation of dihydroartemisinin hemisucinate
IL118200A0 (en) Process for the preparation of substituted 2-fluoro-pyrimidines
IL117078A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them
HRP960357B1 (en) Process for the preparation of lovastatin
IL115090A0 (en) Process for the preparation of p-bromofluorobenzene
IL118973A0 (en) Process for the preparation of substituted aminocarbonyltriazolinones
AU6738496A (en) Process for preparing solid dosage forms of very low-dose drugs
ZA963102B (en) Process for the preparation of streptogramins
HUP9601325A2 (en) Process for the preparation of optionally 2-substituted 5-chloroimidazole-4-carbaldehyde derivatives
HUP9901543A3 (en) Process for the preparation of hydroxysulfone derivatives
IL118732A (en) Process for the preparation of arylidene-substituted alkylcycloalkanones
IL118747A0 (en) Process for the preparation of 3-hydroxyoxetanes
EP0752419A3 (de) Verfahren zur Herstellung von N-substituierten 4-Ketoprolin-Derivaten
ZA965895B (en) Process for the preparation of alpha omega-bromochloro-alkanes
IL117065A0 (en) Process for the preparation of fluorocyclopropane derivatives
ZA96338B (en) Process for the preparation of (1-hydroxycyclohexane)- acetonitrile
HK1009964A1 (en) Process for the preparation of dihaloazolopyrimidines
IL148253A0 (en) Process for the preparation of 4-sulfanylpyrrolidin-2-yl
ZA969296B (en) New process for the preparation of morphinans

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101011